Vir Biotechnology Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
/ 
Frequently asked questions
To buy Vir Biotechnology Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vir Biotechnology Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vir Biotechnology Inc. is VIR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vir Biotechnology Inc. has its primary listing on NASDAQ. You can trade Vir Biotechnology Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vir Biotechnology Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Vir Biotechnology Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Vir Biotechnology Inc..